icon-folder.gif   Conference Reports for NATAP  
 
  The 5th International Workshop on
Clinical Pharmacology of Hepatitis Therapy
Boston, MA June 23-24, 2010
Back grey_arrow_rt.gif
 
 
 
Regulatory Requirements for Early Clinical Testing of Novel HCV Antiviral Drugs: FDA Perspective, Jeff Murray, M.D., M.P.H. FDA, Division of Antiviral Products
 
 
  Reported by Jules Levin
5th International Workshop on Clinical Pharmacology of Hepatitis Therapy
June 23-24, 2010
Boston, MA